← Eichor
Condition: Nasal Cavity Cancer Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Nasal Cavity Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
Phase 1 · 18 location(s) · National Cancer Institute (NCI) · NCT05172245Customized 3D Printed Oral Stents During Head and Neck Radiotherapy
Phase 2 · 7 location(s) · M.D. Anderson Cancer Center · NCT04870762Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal
Phase 2 · 140 location(s) · ECOG-ACRIN Cancer Research Group · NCT03493425Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Can
Phase N/A · 1 location(s) · University of Colorado, Denver · NCT00900419A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT07063212Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants
Phase N/A · 4 location(s) · Vanderbilt University Medical Center · NCT00898638Immunotherapy With Chemotherapy and Chemoradiation for Advanced Squamous Cancer of Nasal Cavity / Paranasal Sinuses (I-N
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT05027633The Head and Neck Registry of the European Reference Network on Rare Adult Solid Cancers
Phase N/A · 10 location(s) · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · NCT05483374Integrated Cancer Repository for Cancer Research
Phase N/A · 42 location(s) · University of Nebraska · NCT02012699A Natural History Study of Children and Adults With Olfactory Neuroblastoma
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT04755205Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone i
Phase 2 · 6 location(s) · National Cancer Institute (NCI) · NCT06980038
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.